搜尋結果
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 1 日前Healthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their ...
Bayer must face US company's flea and tick drug antitrust lawsuit
Reuters· 1 日前, opens new tab must face a U.S. antitrust lawsuit accusing a former unit of the German company ...
Masimo's billionaire CEO put shares on margin to get cash while keeping ownership ahead of ...
CNBC· 1 日前Billionaire Masimo founder Joe Kiani, best known for his successful legal fight against Apple ...
A comprehensive list of 2023 & 2024 tech layoffs
TechCrunch· 1 日前It remains to be seen if this year’s layoff trends follow last year’s, in which layoffs slowed down in the summer, before ...
To Shift to a Circular Economy, Act, Advocate, Advance
The Wall Street Journal· 1 日前Value chains, materials, and market considerations vary by industry and shape each company’s ...
... Releases a New “GetEyeWise” Digital Campaign to Bring Awareness About Eye Health and Visio ...
Bastillepost· 1 日前As May marks Vision Health Month, the Canadian Association of Optometrists (CAO) releases a digital national ...
Jim Cramer shares his thoughts on AMD, Johnson & Johnson, CVS Health, Super Micro and Pinterest ...
CNBC· 2 日前Johnson & Johnson : The pharmaceutical and medical device firm announced a $6.5 billion plan to ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 2 日前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ...
CVS Made a Big Bet on Medicare. It’s Looking Risky.
The Wall Street Journal· 2 日前The company’s Medicare business, hit by higher medical costs, pushed down CVS’s first-quarter earnings.
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 2 日前, opens new tab raised its full-year profit forecast on Wednesday on strong demand for its ...